Not applicableStudy completedNCT02757950
What this trial is testing
A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.
Who this might be right for
Diphtheria
GlaxoSmithKline 2,462